as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹286.35
Change
+1.35 (0.47%)
Open
₹284.0
Prev. Close
₹285.0
Day High
₹288.0
Day Low
₹281.05
Volume Analysis
Traded
722,620
Delivered
445,654
Delivery %
61.67%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong operating margin (27.0%)
Weaknesses (0)
No signal for this stock
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹296.16 | ₹292.08 | ₹289.21 | ₹285.13 | ₹282.26 | ₹278.18 | ₹275.31 |
| Fibonacci | ₹292.08 | ₹289.43 | ₹287.78 | ₹285.13 | ₹282.48 | ₹280.83 | ₹278.18 |
| Camarilla | ₹288.26 | ₹287.62 | ₹286.99 | ₹285.13 | ₹285.71 | ₹285.08 | ₹284.44 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+91.03%
1 Week
+0.58%
1 Month
-1.45%
3 Months
-4.33%
6 Months
+44.6%
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹79.35
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
14.0%
Net margin 16.91% × asset turnover 0.6x × equity multiplier 1.38x
Company Overview
Sector
Healthcare
Market Cap
₹12,368 Cr
P/E (TTM)
44.5
ROE
16.8%
Book Value
₹46.8
Face Value
₹2.0
Source: Screener.in (Consolidated figures) — data as of 26 Sep 2026. Not investment advice.
TopFund Analysis
Park Medi World Limited holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 65/100. The strongest factor is Financial Strength (100/100), while Valuation (12/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (27.0%).
TopFund Score — Fundamentals Quality
65/100 — GoodData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has reduced debt.
- −Though the company is reporting repeated profits, it is not paying out dividend
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Park Group won three honours at Healthcare Pioneers of Delhi 2026; capacity expected to reach 6,600 beds.
Management will skip Anand Rathi G-200 Summit 2026 on Sept 21; other conference plans unchanged.
Park Medi World's subsidiary signed 28-year O&M agreement for 300-bed Kanpur hospital; effective by April 1, 2027.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 348 | 354 | 399 | 410 | 410 | 460 | 476 |
| Expenses + | 265 | 265 | 294 | 297 | 311 | 333 | 350 |
| Operating Profit | 83 | 88 | 105 | 113 | 99 | 127 | 126 |
| OPM % | 24.0% | 25.0% | 26.0% | 27.0% | 24.0% | 28.0% | 26.0% |
| Other Income + | 15 | 9 | 7 | 8 | 9 | 8 | 8 |
| Interest | 16 | 16 | 15 | 15 | 15 | 14 | 10 |
| Depreciation | 15 | 16 | 15 | 15 | 15 | 18 | 19 |
| Profit before tax | 67 | 66 | 82 | 91 | 78 | 103 | 105 |
| Tax % | 32.0% | 20.0% | 20.0% | 14.0% | 32.0% | 26.0% | 16.0% |
| Net Profit + | 46 | 52 | 66 | 79 | 53 | 77 | 89 |
| EPS in Rs | 3 | 1 | 2 | 2 | 1 | 2 | 2 |
| Raw PDF | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales + | 766 | 1,084 | 1,255 | 1,231 | 1,394 | 1,679 | 1,756 |
| Expenses + | 457 | 740 | 863 | 919 | 1,020 | 1,233 | 1,291 |
| Operating Profit | 309 | 345 | 391 | 312 | 374 | 446 | 466 |
| OPM % | 40.0% | 32.0% | 31.0% | 25.0% | 27.0% | 27.0% | 27.0% |
| Other Income + | 3 | 9 | 15 | 29 | 30 | 32 | 32 |
| Interest | 24 | 40 | 51 | 72 | 62 | 61 | 53 |
| Depreciation | 24 | 35 | 41 | 51 | 57 | 62 | 67 |
| Profit before tax | 265 | 278 | 315 | 218 | 286 | 355 | 378 |
| Tax % | 26.0% | 28.0% | 28.0% | 30.0% | 25.0% | 23.0% | — |
| Net Profit + | 187 | 199 | 228 | 152 | 215 | 274 | 297 |
| EPS in Rs | 81 | 12 | 14 | 10 | 5 | 6 | 7 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Reserves | 256 | 380 | 610 | 806 | 975 | 1,936 |
| Borrowings + | 292 | 517 | 576 | 687 | 682 | 364 |
| Other Liabilities + | 249 | 319 | 331 | 343 | 393 | 411 |
| Total Liabilities | 816 | 1,293 | 1,593 | 1,912 | 2,127 | 2,797 |
| Fixed Assets + | 365 | 458 | 536 | 837 | 890 | 1,309 |
| CWIP | 7 | 29 | 5 | 32 | 37 | 123 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 443 | 806 | 1,052 | 1,043 | 1,199 | 1,365 |
| Total Assets | 816 | 1,293 | 1,593 | 1,912 | 2,127 | 2,797 |
| Equity Capital | 19 | 77 | 77 | 77 | 77 | 86 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 223 | 155 | 199 | 367 | 215 | 329 |
| Cash from Investing Activity + | -233 | -248 | -234 | -76 | -100 | -316 |
| Cash from Financing Activity + | 49 | 163 | 1 | -130 | -89 | 121 |
| Net Cash Flow | 39 | 70 | -34 | 161 | 26 | 134 |
| CFO/OP | 96 | 72 | 76 | 150 | 80 | 96 |
| Free Cash Flow | 86 | 64 | 106 | 299 | 70 | 209 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Public | 7.06% | 6.98% | 7.33% |
| Promoters | 82.89% | 82.89% | 82.89% |
| Government | 0.2% | 0.3% | 0.0% |
| FII | 1.28% | 0.86% | 0.82% |
| DII | 8.58% | 8.95% | 8.95% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Park Medi World Limited (this stock) | 12,368 | 44.5 | 6.11 | 16.8% |
| Metropolis Healthcare Ltd | 12,086 | 58.1 | 7.99 | 13.6% |
| Akums Drugs And Pharma L | 12,869 | 42.2 | 3.88 | 8.45% |
| Sudeep Pharma Limited | 13,157 | 72.0 | 14.9 | 25.2% |
| Corona Remedies Limited | 13,219 | 62.3 | 17.73 | 29.5% |
| Blue Jet Healthcare Ltd | 11,040 | 78.3 | — | 52.1% |
| Strides Pharma Sci Ltd | 10,922 | 18.8 | 3.52 | 20.0% |
Which Mutual Funds Hold Park Medi World Limited?
Frequently Asked Questions about Park Medi World Limited
Park Medi World Limited (PARKHOSPS) closed at ₹286.35 on NSE on 25 September 2026, up 1.35 (0.47%) from the previous close.
Park Medi World Limited trades on the NSE (National Stock Exchange of India) under the symbol PARKHOSPS.
Park Medi World Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 44.5.
Park Medi World Limited has a dividend yield of 0.0%.
Park Medi World Limited's 52-week high is ₹305.0 and its 52-week low is ₹138.0.
Park Medi World Limited has a market capitalisation of ₹12,368 crore.
Park Medi World Limited has a TopFund Quality Score of 65/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Park Medi World Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.